Literature DB >> 26865478

Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.

Miroslava Valentova1, Stephan von Haehling2, Juergen Bauditz3, Wolfram Doehner4, Nicole Ebner5, Tarek Bekfani6, Sebastian Elsner6, Veronika Sliziuk6, Nadja Scherbakov6, Ján Murín7, Stefan D Anker2, Anja Sandek8.   

Abstract

AIMS: Mechanisms leading to cachexia in heart failure (HF) are not fully understood. We evaluated signs of intestinal congestion in patients with chronic HF and their relationship with cachexia. METHODS AND
RESULTS: Of the 165 prospectively enrolled outpatients with left ventricular ejection fraction ≤40%, 29 (18%) were cachectic. Among echocardiographic parameters, the combination of right ventricular dysfunction and elevated right atrial pressure (RAP) provided the best discrimination between cachectic and non-cachectic patients [area under the curve 0.892, 95% confidence interval (CI): 0.832-0.936]. Cachectic patients, compared with non-cachectic, had higher prevalence of postprandial fullness, appetite loss, and abdominal discomfort. Abdominal ultrasound showed a larger bowel wall thickness (BWT) in the entire colon and terminal ileum in cachectic than in non-cachectic patients. Bowel wall thickness correlated positively with gastrointestinal symptoms, high-sensitivity C-reactive protein, RAP, and truncal fat-free mass, the latter serving as a marker of the fluid content. Logistic regression analysis showed that BWT was associated with cachexia, even after adjusting for cardiac function, inflammation, and stages of HF (odds ratio 1.4, 95% CI: 1.0-1.8; P-value = 0.03). Among the cardiac parameters, only RAP remained significantly associated with cachexia after multivariable adjustment.
CONCLUSION: Cardiac cachexia was associated with intestinal congestion irrespective of HF stage and cardiac function. Gastrointestinal discomfort, appetite loss, and pro-inflammatory activation provide probable mechanisms, by which intestinal congestion may trigger cardiac cachexia. However, our results are preliminary and larger studies are needed to clarify the intrinsic nature of this relationship. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Cachexia; Heart failure; Intestinal congestion; Right ventricular function

Mesh:

Year:  2016        PMID: 26865478     DOI: 10.1093/eurheartj/ehw008

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  54 in total

Review 1.  Progress in heart failure treatment in Germany.

Authors:  Mark Luedde; Martina E Spehlmann; Norbert Frey
Journal:  Clin Res Cardiol       Date:  2018-07-02       Impact factor: 5.460

Review 2.  Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic?

Authors:  Lucas N L Van Aelst; Dominiek Mazure; Alain Cohen-Solal
Journal:  Curr Heart Fail Rep       Date:  2017-08

Review 3.  Ultrasonographic assessment of organs other than the heart in patients with heart failure.

Authors:  Kazuhiro Yamamoto; Yoshiharu Kinugasa; Shinobu Sugihara; Natsuko Mukai-Yatagai; Masahiko Kato
Journal:  J Med Ultrason (2001)       Date:  2019-06-11       Impact factor: 1.314

4.  Portal congestion and intestinal edema in hospitalized patients with heart failure.

Authors:  Yuki Ikeda; Shunsuke Ishii; Mayu Yazaki; Teppei Fujita; Yuichiro Iida; Toyoji Kaida; Takeru Nabeta; Eiji Nakatani; Emi Maekawa; Tomoyoshi Yanagisawa; Toshimi Koitabashi; Takayuki Inomata; Junya Ako
Journal:  Heart Vessels       Date:  2018-01-11       Impact factor: 2.037

5.  Associations of depression severity with heart rate and heart rate variability in young adults across normative and clinical populations.

Authors:  Laura M Lesnewich; Fiona N Conway; Jennifer F Buckman; Christopher J Brush; Peter J Ehmann; David Eddie; Ryan L Olson; Brandon L Alderman; Marsha E Bates
Journal:  Int J Psychophysiol       Date:  2019-06-10       Impact factor: 2.997

Review 6.  Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension.

Authors:  Nils P Nickel; Ke Yuan; Peter Dorfmuller; Steeve Provencher; Yen-Chun Lai; Sebastien Bonnet; Eric D Austin; Carl D Koch; Alison Morris; Frédéric Perros; David Montani; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

7.  Non-occlusive mesenteric ischemia in a patient with left ventricular assist device implantation.

Authors:  Takaaki Samura; Koichi Toda; Daisuke Yoshioka; Hidekazu Takahashi; Shigeru Miyagawa; Yasushi Yoshikawa; Shunsuke Saito; Keitaro Domae; Yoshiki Sawa
Journal:  J Artif Organs       Date:  2017-06-03       Impact factor: 1.731

Review 8.  Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).

Authors:  Veli-Pekka Harjola; Wilfried Mullens; Marek Banaszewski; Johann Bauersachs; Hans-Peter Brunner-La Rocca; Ovidiu Chioncel; Sean P Collins; Wolfram Doehner; Gerasimos S Filippatos; Andreas J Flammer; Valentin Fuhrmann; Mitja Lainscak; Johan Lassus; Matthieu Legrand; Josep Masip; Christian Mueller; Zoltán Papp; John Parissis; Elke Platz; Alain Rudiger; Frank Ruschitzka; Andreas Schäfer; Petar M Seferovic; Hadi Skouri; Mehmet Birhan Yilmaz; Alexandre Mebazaa
Journal:  Eur J Heart Fail       Date:  2017-05-30       Impact factor: 15.534

Review 9.  Muscle wasting and cachexia in heart failure: mechanisms and therapies.

Authors:  Stephan von Haehling; Nicole Ebner; Marcelo R Dos Santos; Jochen Springer; Stefan D Anker
Journal:  Nat Rev Cardiol       Date:  2017-04-24       Impact factor: 32.419

Review 10.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.